查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
主动脉瘤市场规模、份额和趋势分析报告：按类型（TAA、AAA）、按治疗（OSR、EVAR）、按产品（支架移植物、导管）、按最终用户、按地区、分部预测，2022~2030
市场调查报告书
商品编码
1122255

主动脉瘤市场规模、份额和趋势分析报告：按类型（TAA、AAA）、按治疗（OSR、EVAR）、按产品（支架移植物、导管）、按最终用户、按地区、分部预测，2022~2030

Aortic Aneurysm Market Size, Share & Trends Analysis Report By Type (TAA, AAA), By Treatment (OSR, EVAR), By Product (Stent Grafts, Catheters), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10个工作天内

价格

主动脉瘤市场增长和趋势

根据Grand View Research, Inc.最新报告，到2030年全球主动脉瘤市场规模将达到65亿美元，到2030年全球主动脉瘤治疗市场规模将达到104亿美元，到2022年. 预计2020-2030年復合年增长率为10.51%。

发达国家老年人口的增长、久坐不动的生活方式的迅速采用以及吸烟者人数的增加预计将成为推动全球市场的主要因素。美国心臟协会（American Heart Association Inc.）发表的一项研究发现，大于 4 厘米的 AAAs 的超额患病率中有 75% 被认为是由吸烟引起的。此外，血管内手术的技术进步将促进行业增长。

腹主动脉瘤的病例数，特别是在 65 岁及以上的男性中，是胸主动脉瘤病例数的三倍。这增加了 AAA 对先进覆膜支架系统的需求。由于缺乏多种治疗选择和程序的复杂性，TAA 手术的数量很少。这为製造商开髮用于胸腔内动脉瘤修復 (TEVAR) 的先进产品提供了有利可图的机会。

COVID-19 大流行对 AA 市场产生了负面影响。许多政府机构，包括美国外科医师学会和法国血管外科学会，都建议推迟简单的 AA 手术。许多医院限制与主动脉疾病相关的手术，更喜欢 EAVR 而非开放手术。结果，用于治疗主动脉疾病的设备的销售额直线下降。例如，Microport Scientific Corporation 的血管内业务部门的收入将在 2021 年下降 42.1%。

主动脉瘤市场报告亮点

按类型划分，AAA 细分市场在 2021 年占据市场主导地位。AAA 病例数量的增加、政府早期筛查项目的存在以及对微创手术的需求不断增长正在推动这一细分市场

按产品划分，支架移植物将占 2021 年最大的收入份额，因为它们占患者手术总成本的 50% 以上

从最终用户来看，由于技术进步和手术数量的增加，预计对医院的销售将强劲。

通过治疗方式，涉及微创手术的血管内主动脉瘤修復（EVAR）预计将成为预测期内增长最快的部分，因为它比开放式修復更有效，术后副作用更少。

北美将在 2021 年占据最大的销售额份额，其次是欧洲。这是由于完善的医疗基础设施、先进的 AAA 筛查和诊断工具的可用性以及该地区有利的报销方案。

2021年8月，Terumo Corporation 获得美国 FDA 批准上市 RelayPro 胸腔支架移植系统，用于治疗胸主动脉瘤和穿透性动脉硬化性溃疡患者。

目录

第一章研究范围与目的

  • 市场细分
  • 区域范围
  • 研究目标

第二章研究方法论

  • 调查方法
    • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 量价分析
  • 二级信息列表
  • 缩略语表

第三章执行摘要

  • 市场展望
  • 分部展望
    • 类型
    • 过程
    • 产品
    • 最终用途
  • 区域展望
  • 竞争考虑

第 4 章市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场展望
  • 主动脉瘤市场动态
    • 市场驱动力分析
    • 市场约束分析
  • 主动脉瘤市场：商业环境分析工具
    • 波特五力分析
      • 新进入者的威胁
      • 买方议价能力
      • 竞争对手之间的竞争
      • 替代品的威胁
      • 供应商的议价能力
    • 杵分析
      • 政治与法律
      • 经济与社会
      • 技术的
  • 绘製渗透率和增长前景
  • 定性分析：COVID-19 对主动脉瘤市场的影响

5. 主动脉瘤市场：类型分析

  • 2021 年和 2030 年主动脉瘤类型市场份额分析
  • 主动脉瘤类型市场：细分仪表板
  • 类型细分市场规模和预测，趋势分析，2016-2030
    • 胸主动脉瘤 (TAA)
    • 腹主动脉瘤 (AAA)

6 主动脉瘤市场：治疗分析

  • 2021 年和 2030 年主动脉瘤治疗市场份额分析
  • 主动脉瘤治疗市场：细分仪表板
  • 2016-2030年治疗细分市场规模及预测、趋势分析
    • 开放式手术修復 (OSR)
    • 血管内动脉瘤修復（EVAR）

7. 主动脉瘤市场：产品分析

  • 2021 年和 2030 年主动脉瘤产品市场份额分析
  • 主动脉瘤产品市场：细分仪表板
  • 产品细分市场规模和预测，趋势分析，2016-2030
    • 覆膜支架
    • 导管

8 主动脉瘤市场：最终用途分析

  • 2021 年和 2030 年主动脉瘤最终用途市场份额分析
  • 主动脉瘤最终用途市场：细分仪表板
  • 2016-2030 年最终用途细分市场规模及预测及趋势分析
    • 医院
    • 门诊手术中心
    • 诊所

9. 主动脉瘤市场：区域分析

  • 2021 年和 2030 年主动脉瘤区域市场份额分析
  • 区域市场快照
  • 2016-2030 年市场规模、预测和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
    • 拉丁美洲
      • 墨西哥
      • 巴西
    • 中东和非洲
      • 南非
      • 沙特阿拉伯

第 10 章 竞争分析

  • 主要市场参与者的最新发展和影响分析
  • 竞争对手分类（主要创新者、市场领导者、初创企业）
  • 公司市场分析
  • 公司简介
    • MEDTRONIC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • TERUMO CORPORATION
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • ENDOLOGIX LLC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • MICROPORT SCIENTIFIC CORPORATION
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • GORE MEDICAL（WL GORE &ASSOCIATES）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • COOK
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • JOTEC（CRYOLIFE, INC.）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • LOMBARD MEDICAL
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-3-68038-043-9

Aortic Aneurysm Market Growth & Trends:

The global aortic aneurysm market size is expected to reach USD 6.5 billion by 2030 and the global aortic aneurysm treatment market size is expected to reach USD 10.4 billion by 2030, expanding at a CAGR of 10.51% from 2022 to 2030, according to a new report by Grand View Research, Inc.

The growing geriatric population in developed countries, rapid adoption of sedentary lifestyles, and a rise in the number of tobacco smokers are expected to be the key factors driving the global market. According to a study published by the American Heart Association Inc., it was found that smoking was considered to be responsible for 75% of the excess prevalence of AAAs ≥4 cm. Furthermore, technological advancements in endovascular surgical procedures will augment the industry's growth.

Cases of abdominal aortic aneurysms, especially in men aged 65 years and above, surpassed the number of thoracic aortic aneurysms by threefold. This has increased the demand for advanced stent-graft systems for AAA. Due to the lack of multiple treatment options and being a complex procedure, TAA procedures are fewer. This offers a lucrative opportunity to the manufacturers for developing advanced products for Thoracic Endovascular Aneurysm Repair (TEVAR).

The COVID-19 pandemic negatively impacted the AA market. Many government associations such as the American College of Surgeons and the French Vascular Surgical Society recommended the postponement of uncomplicated AA procedures. Many hospitals limited surgical activity related to aortic diseases, with EAVR being preferred over open surgery. As a result, the sales of AA devices reported a sharp decline. For instance, the endovascular segment of Microport Scientific Corporation witnessed a decline of 42.1% in revenue in 2021.

Aortic Aneurysm Market Report Highlights:

  • Based on type, the AAA segment dominated the market in 2021. The rising number of AAA cases, the presence of government programs for early screening, and increasing demand for minimally invasive procedures are driving the segment
  • In terms of product, stent-grafts held the largest revenue share in 2021 as they have more than 50% share in the overall surgical treatment cost of a patient
  • Based on end-use, the hospital's segment is expected to flourish owing to a rise in technological advancement and high procedure volume
  • By treatment, Endovascular Aortic Aneurysm Repair (EVAR), which includes minimally invasive surgeries, is expected to be the fastest-growing segment over the forecast period as it is more efficient than open repair due to fewer postsurgical adverse effects
  • North America held the largest revenue share in 2021, followed by Europe, on account of well-established healthcare infrastructure, access to advanced screening and diagnostic tools for AAA, and favorable reimbursement scenario in the region
  • In August 2021, Terumo Corporation received approval by the U.S. FDA for its RelayPro Thoracic Stent-Graft System to be sold in the U.S. to treat patients with thoracic aortic aneurysm and penetrating atherosclerotic ulcers

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
    • 2.1.2 Purchased Database
    • 2.1.3 GVR's Internal Database
    • 2.1.4 Secondary Sources
    • 2.1.5 Primary Research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data Analysis Models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Volume Price Analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Abbreviations

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Type
    • 3.2.2 Treatment
    • 3.2.3 Product
    • 3.2.4 End-use
  • 3.3 Regional Outlook
  • 3.4 Competitive Insights

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Related/Ancillary Market Outlook
  • 4.2 Aortic Aneurysm Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Aortic Aneurysm Market: Business Environment Analysis Tools
    • 4.3.1 Porter's five forces analysis
      • 4.3.1.1 Threat of new entrants
      • 4.3.1.2 Bargaining power of buyers
      • 4.3.1.3 Competitive rivalry
      • 4.3.1.4 Threat of substitutes
      • 4.3.1.5 Bargaining power of suppliers
    • 4.3.2 PESTLE Analysis
      • 4.3.2.1 Political & legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Qualitative Analysis: Impact of COVID-19 on Aortic Aneurysm Market

Chapter 5 Aortic Aneurysm Market: Type Analysis

  • 5.1 Aortic Aneurysm Type Market Share Analysis, 2021 & 2030
  • 5.2 Aortic Aneurysm Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the Type Segment
    • 5.3.1 Thoracic Aortic Aneurysm (TAA)
      • 5.3.1.1 Thoracic aortic aneurysm (TAA) market, 2016 - 2030 (USD Million)
    • 5.3.2 Abdominal Aortic Aneurysm (AAA)
      • 5.3.2.1 Abdominal aortic aneurysm (AAA)market, 2016 - 2030 (USD Million)

Chapter 6 Aortic Aneurysm Market: Treatment Analysis

  • 6.1 Aortic Aneurysm TreatmentMarket Share Analysis, 2021 & 2030
  • 6.2 Aortic Aneurysm TreatmentMarket: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the TreatmentSegment
    • 6.3.1 Open Surgical Repair (OSR)
      • 6.3.1.1 Open surgical repair market, 2016 - 2030 (USD Million)
    • 6.3.2 Endovascular Aneurysm Repair (EVAR)
      • 6.3.2.1 Endovascular aneurysm repair (EVAR) market, 2016 - 2030 (USD Million)

Chapter 7 Aortic Aneurysm Market: Product Analysis

  • 7.1 Aortic Aneurysm ProductMarket Share Analysis, 2021 & 2030
  • 7.2 Aortic Aneurysm Product Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the ProductSegment
    • 7.3.1 Stent Grafts
      • 7.3.1.1 Stent grafts market, 2016 - 2030 (USD Million)
    • 7.3.2 Catheter
      • 7.3.2.1 Catheter market, 2016 - 2030 (USD Million)

Chapter 8 Aortic Aneurysm Market: End-Use Analysis

  • 8.1 Aortic Aneurysm End-Use Market Share Analysis, 2021 & 2030
  • 8.2 Aortic Aneurysm End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1Hospitals market, 2016 - 2030 (USD Million)
    • 8.3.2 Ambulatory Surgery Centers
      • 8.3.2.1 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
    • 8.3.3 Clinics
      • 8.3.3.1 Clinics market, 2016 - 2030 (USD Million)

Chapter 9 Aortic Aneurysm Market: Regional Analysis

  • 9.1 Aortic Aneurysm Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 Market Size, & Forecasts and Trend Analysis, 2016 to 2030
    • 9.3.1 North America
      • 9.3.1.1 North America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.2 U.S.
      • 9.3.1.2.1 U.S. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.3 Canada
      • 9.3.1.3.1 Canada Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.2 Europe
      • 9.3.2.1 Europe Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.2 U.K.
      • 9.3.2.2.1 U.K. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.3 Germany
      • 9.3.2.3.1 Germany Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.4 France
      • 9.3.2.4.1 France Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.5 Italy
      • 9.3.2.5.1 Italy Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.6 Spain
      • 9.3.2.6.1 Spain Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.3 Asia Pacific
      • 9.3.3.1 Asia Pacific Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.2 Japan
      • 9.3.3.2.1 Japan Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.3 China
      • 9.3.3.3.1 China Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.4 India
      • 9.3.3.4.1 India Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.5 Australia
      • 9.3.3.5.1 Australia Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.6 South Korea
      • 9.3.3.6.1South Korea Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.4 Latin America
      • 9.3.4.1 Latin America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.2 Mexico
      • 9.3.4.2.1 Mexico Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.3 Brazil
      • 9.3.4.3.1 Brazil Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.5 Middle East & Africa
      • 9.3.5.1 MiddleEast & Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.2 South Africa
      • 9.3.5.2.1 South Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.3 Saudi Arabia
      • 9.3.5.3.1 Saudi Arabia Aortic Aneurysm Market, 2016 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.3 Company Market Position Analysis
  • 10.4 company profiles
    • 10.4.1 MEDTRONIC
      • 10.4.1.1 Company overview
      • 10.4.1.2 Financial performance
      • 10.4.1.3 Product benchmarking
      • 10.4.1.4 Strategic initiatives
    • 10.4.2 TERUMO CORPORATION
      • 10.4.2.1 Company overview
      • 10.4.2.2 Financial performance
      • 10.4.2.3 Product benchmarking
      • 10.4.2.4 Strategic initiatives
    • 10.4.3 ENDOLOGIX LLC
      • 10.4.3.1 Company overview
      • 10.4.3.2 Financial performance
      • 10.4.3.3 Product benchmarking
      • 10.4.3.4 Strategic initiatives
    • 10.4.4 MICROPORT SCIENTIFIC CORPORATION
      • 10.4.4.1 Company overview
      • 10.4.4.2 Financial performance
      • 10.4.4.3 Product benchmarking
      • 10.4.4.4 Strategic initiatives
    • 10.4.5 GORE MEDICAL (W. L. GORE & ASSOCIATES)
      • 10.4.5.1 Company overview
      • 10.4.5.2 Financial performance
      • 10.4.5.3 Product benchmarking
      • 10.4.5.4 Strategic initiatives
    • 10.4.6 COOK
      • 10.4.6.1 Company overview
      • 10.4.6.2 Financial performance
      • 10.4.6.3 Product benchmarking
      • 10.4.6.4 Strategic initiatives
    • 10.4.7 JOTEC (CRYOLIFE, INC.)
      • 10.4.7.1 Company overview
      • 10.4.7.2 Financial performance
      • 10.4.7.3 Product benchmarking
      • 10.4.7.4 Strategic initiatives
    • 10.4.8 LOMBARD MEDICAL
      • 10.4.8.1 Company overview
      • 10.4.8.2 Financial performance
      • 10.4.8.3 Product benchmarking
      • 10.4.8.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 North America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 4 North America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 5 North America Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 6 North America Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 7 North America Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 8 U.S. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 9 U.S. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 10 U.S. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 11 U.S. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 12 Canada Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 13 Canada Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 14 Canada Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 15 Canada Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 16 Europe Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 17 Europe Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 18 Europe Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 19 Europe Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 20 Europe Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 U.K. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 22 U.K. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 23 U.K. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 24 U.K. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25Germany Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 26 Germany Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 27 Germany North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 28 Germany Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 France Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 30 France Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 31 France North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 32 France Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Italy Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 34 Italy Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 35 Italy North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 36 Italy Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Spain Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 38 Spain Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 39 Spain North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 40 Spain Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Asia Pacific Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 42 Asia Pacific Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 43 Asia Pacific Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 44 Asia Pacific Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 45 Asia Pacific Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 46 Japan Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 47 Japan Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 48 Japan Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 49 Japan Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 50 China Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 51 China Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 52 China Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 53 China Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 54 India Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 55 India Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 56 India Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 57 India Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 58 Australia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 59 Australia Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 60 Australia Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 61 Australia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 62 South Korea Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 63 South Korea Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 64 South Korea Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 65 South Korea Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 66 Latin America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 67 Latin America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 68 Latin America Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 69 Latin America Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 70 Latin America Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 71 Brazil Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 72 Brazil Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 73 Brazil Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 74 Brazil Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 75 Mexico Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 76 Mexico Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 77 Mexico Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 78 Mexico Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 79 Middle East & Africa Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 80 Middle East & Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 81 Middle East & Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 82 Middle East & Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 83 Middle East & Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 84 South Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 85 South Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 86 South Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 87 South Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 88 Saudi Arabia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 89 Saudi Arabia Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 90 Saudi Arabia Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook
  • FIG. 9 Aortic aneurysm market segmentation
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 Market dynamics
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Aortic aneurysm type market share analysis, 2021 & 2030
  • FIG. 15 Aortic aneurysm type market: Segment dashboard
  • FIG. 16 Thoracic aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 17 Abdominal aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 18 Aortic aneurysm treatment type market share analysis, 2021 & 2030
  • FIG. 19 Aortic aneurysm treatment type market: Segment dashboard
  • FIG. 20 Open surgical repair market, 2016 - 2030 (USD Million)
  • FIG. 21 Endovascular aneurysm repair(EVAR), 2016 - 2030 (USD Million)
  • FIG. 22 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 23 Aortic Aneurysm Product Market: Segment dashboard
  • FIG. 24 Stent grafts market, 2016 - 2030 (USD Million)
  • FIG. 25 Catheters market, 2016 - 2030 (USD Million)
  • FIG. 26 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 27 Aortic aneurysm product market: Segment dashboard
  • FIG. 28 Hospitals market, 2016 - 2030 (USD Million)
  • FIG. 29 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
  • FIG. 30 Clinics market, 2016 - 2030 (USD Million)
  • FIG. 31 Aortic aneurysm regional market share analysis, 2021 & 2030
  • FIG. 32 Aortic aneurysm regional market: Segment dashboard
  • FIG. 33 Regional marketplace: Key takeaways
  • FIG. 34 North America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 35 U.S. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 36 Canada aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 37 Europe aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 38 U.K.. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 39 Germany aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 40 France aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 41 Italy aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 42 Spain aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 43 Asia Pacific aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 44 Japan aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 45 China aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 46 India aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 47 Australia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 48 South Korea aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 49 Latin America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 50 Brazil aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 51 Mexico aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 52 MEA aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 53South Africa aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 54 Saudi Arabia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 55 Recent developments & impact analysis, by key market participants
  • FIG. 56 Strategic framework/ competition categorization
  • FIG. 57 Company market position analysis